Association of vitamin D receptor gene polymorphism with type 1 diabetes mellitus in two Spanish populations;Asociación de los polimorfismos-del gen del receptor de la vitamina D con la diabetes mellitus tipo 1 en dos poblaciones españolas

Medicina Clinica

Volumn 123, Issue 8, 2004, Pages 286-290

  Martí, Gertrudis ^a   Audí, Laura ^a,c   Esteban, Cristina ^a   Oyarzábal, Miren ^b   Chueca, María ^b   Gussinyé, Miquel ^a   Yeste, Diego ^a   Fernández Cancio, Mónica ^a   Andaluz, Pilar ^a   Carrascosa, Antonio ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Universidad Pública de Navarra   (Spain)

^c HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

Gene; Polymorphism; RFLP; Type 1 diabetes mellitus; Vitamin D receptor

Indexed keywords

VITAMIN D RECEPTOR;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ETHNIC GROUP; EXON; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; MAJOR CLINICAL STUDY; MALE;

EID: 5644269232     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(04)74494-2     Document Type: Article

References (48)

1. The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 1998;42:51-4.
2. Hyppönen E, Läärä E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-3.
3. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of type 1 diabetes in the offspring. Diabetologia 2000;43:1093-8.
4. Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? P Soc Exp Biol Med 2000;223:230-3.
5. McGrath J. Does «imprinting» with low prenatal vitamin D contribute to the risk of various adult disorders? Med Hypotheses 2001;56:367-71.
6. Harris S. Can vitamin D supplementation in infancy prevent type 1 diabetes? Nutr Rev 2002; 60:118-21.
7. Mathieu C, Waer M, Laureys J, Rutgeers O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994;37:552-8.
8. Casteels KM, Mathieu C, Waer M, Valckx D, Overbergh L, Laureys JM, et al. Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction of cyclosporin A. Endocrinology 1998;139:95-102.
9. 3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002;51:1367-74.
10. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998;78:1193-231.
11. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003;17:509-11.
12. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000;22:203-17.
13. Császár A, Abel T. Receptor polymorphisms and diseases. Eur J Pharmacol 2001;414:9-22.
14. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998;13:325-49.
15. McDermott MF, Ramachandran A, Ogunkolade BW, Aganna E, Curtis D, Boucher BJ, et al. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997;40:971-5.
16. Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH, et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000;49: 504-7.
17. Guja C, Marshall S, Welsh K, Merriman M, Smith A, Todd JA, et al. The study of CTLA-4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population. J Cell Mol Med 2002; 6:75-81.
18. Chang TJ, Lei HH, Yeh JI, Chiu KC, Lee KC, Chen MC, et al. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol 2000;52:575-80.
19. Fassbender WJ, Goertz B, Weismuller K, Steinhauer B, Stracke H, Auch D, et al. VDR gene polymorphisms are overexpressed in German patients with type 1 diabetes compared to healthy controls without effect on biochemical parameters of bone metabolism. Horm Metab Res 2002;34:330-7.
20. Skrabic W, Zemunik T, Situm M, Terzic J. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Dalmatian population. Diabetes Res Clin Pract 2003;59:31-5.
21. Hitman GA, Mannan N, McDermott MF, Aganna E, Ogunkolade W, Hales CN, et al. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes 1998; 47:688-90.
22. Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002;51:2294-312.
23. Lahiri DK, Nurnberger JI Jr. A rapid non enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
24. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996;11: 1850-5.
25. Sosa M, Torres A, Martín N, Salido E, Liminana JM, Barrios Y, et al. The distribution of two different vitamin D receptor polymorphisms (BsmI and start codon) in primary hyperparathyroidism. J Intern Med 2000;247:124-30.
26. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367: 284-7.
27. Minamitani K, Takahashi Y, Minagawa M, Yasuda T, Niimi H. Difference in height associated with a translation start site polymorphism in the vitamin D receptor gene. Pediatr Res 1998;44: 628-32.
28. Suarez F, Rossignol C, Garabédian M. Interactive effect of estradiol and vitamin D receptor gene polymorphisms as a possible determinant of growth in male and female infants. J Clin Endocrinol Metab 1998;83:3563-8.
29. Sosa Enríquez M, Torres Ramírez A, Domínguez Cabrera C, Salido E, Saavedra Santana P, Barrios Y, et al. Polimorfismo genético del receptor de la vitamina D y osteoporosis. Med Clin (Barc) 1998; 110:646-50.
30. Bernad M, Jaramillo G, Aguado P, Del Campo T, Coya J, Martín Mola E, et al. Polimorfismo del gen del receptor de la vitamina D y densidad mineral ósea en mujeres posmenopáusicas. Med Clin (Barc) 1999;112:651-5.
31. Lorentzon M, Lorentzon R, Nordström P. Vitamin D receptor gene polymorphism is associated with birth height, growth to adolescence, and adult stature in healthy Caucasian men: a cross-sectional and longitudinal study. J Clin Endocrinol Metab 2000;85:1666-71.
32. Zarrabeitia MT, Riancho JA, Franco-Vicario R, Goiria J, Gonzalo C, González-Macias J. Tipado genético múltiple (receptor de la vitamina D y de estrógenos) en la evaluación del riesgo de fracturas. Med Clin (Barc) 2000;114:241-4.
33. Manzano C, Aguirre AI, Iriondo M, Martín M, Osaba L, De la Rua C. Genetic polymorphisms of the Basques from Guipuzkoa: genetic heterogeneity of the Basque population. Ann Hum Biol 1996;23:285-96.
34. Pena JA, Calderón R, Pérez-Miranda A, Vidales C, Dugoujon JM, Carrión M, et al. Microsatellite DNA markers from HLA region (D6S105, D6S265 and TNFa) in autochthonous Basques from Northern Navarre (Spain). Ann Hum Biol 2002;29:176-91.
35. Cambon-de Mouzon A, Ohayon E, Hauptmann G, Sevin A, Abbal M, Sommer E, et al. HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 1982;19:366-79.
36. Urrutia I, Calvo B, Bilbao JR, Castaño L. Anomalous behaviour of the 5′ insulin gene polymorphism allele 814: lack of association with Type I diabetes in Basques. GEPV-N Group. BasqueNavarre Endocrinology and Paediatrics. Diabetologia 1998;41:1121-3.
37. Pérez de Nanclares G, Bilbao JR, Calvo B, Castaño L Analysis of chromosome 6q in Basque families with type 1 diabetes. Gepv-N. BasqueNavarre Endocrinology and Paediatric Group. Autoimmunity 2000;33:33-6.
38. Bilbao JR, Martín-Pagola A, Calvo B, Pérez de Nanclares G, Gepv-N, Castaño L. Contribution of MIC-A polymorphism to type 1 diabetes mellitus in Basques. Ann N Y Acad Sci 2002;958: 321-4.
39. Ezquieta B, Cueva E, Oyarzabal M, Oliver A, Varela JM, Jariego C. Gene conversion (655G splicing mutation) and the founder effect (Gln318Stop) contribute to the most frequent severe point mutations in congenital adrenal hyperplasia (21-hydroxylase deficiency) in the Spanish population. Clin Genet 2002;62:181-8.
40. Howard G, Nguyen T, Morrison N, Watanabe T, Sambrook P, Eisman J, et al. Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. Notification of genotype corrections. (Letter). J Clin Endocrinol Metab 1998;83:1043.
41. Eisman JA. Genetics of osteoporosis. Endocr Rev 1999;20:788-804.
42. Giguère Y, Rousseau F. The genetics of osteoporosis: «complexities and difficulties». Clin Genet 2000;57:161-9.
43. Hauache OM, Lazaretti-Castro M, Andreoni S, Gimeno SGA, Brandao C, Ramalho AC, et al. Vitamin D receptor gene polymorphism: correlation with bone mineral density in a Brazilian population with insulin-dependent diabetes mellitus. Osteoporos Int 1998;8:204-10.
44. Taverna MJ, Sola A, Guyot-Argenton C, Pacher N, Bruzzo F, Slama G, et al. TaqI polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia 2002;45:436-42.
45. Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res 1998;13:1691-9.
46. Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhäger JC, Pols HAP, et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3. Clin Endocrinol 2000;52: 211-6.
47. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000;14:401-20.
48. Fischer PR, Thacher TD, Pettifor JM, Jorde LB, Eccleshall TR, Feldman D. Vitamin D receptor polymorphisms and nutritional rickets in Nigerian children. J Bone Miner Res 2000;15:2206-10.